Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy
2023 · CNS Drugs · 10 citations
https://doi.org/10.1007/s40263-023-00992-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
69
Papers
2.5K
Citations
21
h-index
29
i10-index
Roman Skowroński is an academic researcher from Jazz Pharmaceuticals (United States). The author has contributed to research in topics: Sleep and Wakefulness Research & Sleep and related disorders & Vitamin D Research Studies. The author has an h-index of 21, co-authored 59 publications.
Click to start Chat